Bill Hinshaw, Axcella CEO

Ax­cel­la seeks 'light speed' swing at long Covid, but needs cash

In De­cem­ber, Ax­cel­la laid off 85% of its work­force and said it was look­ing for “strate­gic al­ter­na­tives,” but for now it’s still push­ing for­ward with its long Covid tri­al plans.

In an in­vestor call Tues­day morn­ing, Ax­cel­la out­lined a late-stage tri­al de­sign. It plans to en­roll around 300 pa­tients in a study us­ing a fa­tigue ques­tion­naire known as the CFQ 11, which it used in its pre­vi­ous Phase II tri­al, as the pri­ma­ry end­point. And Ax­cel­la said that it’s aligned with UK au­thor­i­ties on that end­point.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.